Exane Derivatives’s SouthState Bank Corp SSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$111K Buy
1,444
+42
+3% +$3.27K 0.06% 252
2022
Q1
$114K Buy
+1,402
New +$121K 0.03% 450

Other funds holding SSB

Exane Derivatives's SSB Position: Q2 2022 in Review

Exane Derivatives increased its SouthState Bank Corp (SSB) stake by 3% in Q2 2022, buying an estimated $3.27K and bringing the position to 1,444 shares worth $111K. The position accounts for 0.06% of the portfolio, ranked #252.

Exane Derivatives first reported a position in SSB in Q1 2022 and has held it in 2 quarters since. The position peaked at $114K in Q1 2022. 312 funds tracked by Wall St. Rank hold SSB as of Q2 2022.

  • Exane Derivatives held 1,444 shares of SouthState Bank Corp worth $111K as of Q2 2022.
  • Exane Derivatives bought 42 SouthState Bank Corp shares in Q2 2022, an estimated $3.27K.
  • SouthState Bank Corp made up 0.06% of Exane Derivatives's portfolio in Q2 2022, its #252 holding.
  • Exane Derivatives first reported a position in SouthState Bank Corp in Q1 2022 and has held it in 2 quarters since.
  • Exane Derivatives's SouthState Bank Corp position peaked at $114K in Q1 2022.
  • 312 funds tracked by Wall St. Rank held SouthState Bank Corp as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.